The DDA Infusion Suites
At the DDA Infusion Centers located in Catonsville and Columbia, we treat patients with autoimmune disorders such as Crohn’s Disease and Ulcerative Colitis. Patients with rheumatoid arthritis, psoriatic arthritis and psoriasis are also treated at the Centers. These diseases result from the overproduction of tumor necrosis factor (TNF), a type of cell that causes inflammation. This inflammation can be found in the GI tract, joints and/or skin, and can lead to disease flares.
One of the medications we infuse, Remicade (infliximab), is often referred to as an “anti-TNF agent” or “steroid sparing” medication. Remicade is a highly engineered medication (a monoclonal antibody) that is designed to block the activity of TNF leading to decreased inflammation and the improvement of symptoms related to the disease. The goal of Remicade is to reduce the signs and symptoms of moderate to severe disease activity, thereby lessening the long term complications of the disease.
We have strived to make our infusion centers as comfortable and as user friendly as possible. It is our belief that just because our patients have chronic diseases doesn’t mean they should be treated like “sick” patients. Below are some of the comments from patients of the Center:
- “there is a social atmosphere,”
- “it’s great to talk to other patients with similar issues,”
- “it’s the only time I don’t hear mommy, mommy,”
- “we feel well cared for,” and
- “I’ve had infusions in the hospital, but I prefer to come to DDA.”